ClinicalTrials.Veeva

Menu

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts

Abramson Cancer Center at Penn Medicine logo

Abramson Cancer Center at Penn Medicine

Status

Active, not recruiting

Conditions

Breast Diseases

Treatments

Diagnostic Test: Fast Breast Abbreviated Magnetic Renounce Imaging

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT examination 11 months prior to recruitment 3. Heterogeneously and Extremely breast densities 4. clinically asymptomatic- no palpable masses, focal thickening or clinically significant discharge. Investigators will identify these patients EPIC database utilizing the date of their last mammogram. Interested patients may contact our research coordinators by the phone number provided in the recruitment materials. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.

Full description

500 patients will be prospectively recruited to undergo an abbreviated or "FAST" breast MRI examination. The women will be recruited for the study must meet the following criteria: 1. African American 2. negative DBT examination no more than 11 months prior to the FAST MR 3. Heterogeneously and Extremely breast densities as graded on their most recent mammogram 4. clinically asymptomatic- no palpable masses, focal thickening or clinically significant nipple discharge. Investigators will identify these women via the EPIC database utilizing the date of their last mammogram. Interested women may contact our research coordinators by the phone number provided in the recruitment materials. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.

Enrollment

500 estimated patients

Sex

Female

Ages

40 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. African American female
  2. Negative DBT examination within eleven months prior to recruitment
  3. Heterogeneoulsy and Extremely breast densities
  4. Clinically asymptomatic- no palpable masses or focal thickening, etc.

Exclusion criteria

  1. Patients who are pregnant and lactating
  2. Patient who have not had a mammogram (DBT) in the past 11months
  3. Patients who are unwilling or unable to provide written informed consent
  4. Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, ect.)
  5. Recent breast surgery in the past 2 years including breast enhancements (e.g. implants or injections)
  6. Patients who are unable to received an MRI with Gadolinium contrast
  7. Patients who have not had an MRI of the breast with the past year

Trial contacts and locations

1

Loading...

Central trial contact

Jessica Nunez; Isabella Strickler

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems